• 982
    0

    Two clinical trials have shown early promise in treating common blindness-causing conditions, specifically the dry form of macular degeneration, by injecting embryonic stem cells behind the human retina. This treatment may be able to prevent the onset of vision-damaging disease and even improve patients’ vision. “We’re encouraged by the results thus far,” said Eyal Banin, ...